Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $241.0K | $242.0K | $1.5M | $2.3M | $4.9M | $10.0M | $6.1M | $7.7M |
| Gross profit | −$241.0K | −$242.0K | −$1.5M | −$2.3M | −$4.9M | −$10.0M | −$6.1M | −$7.7M |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $18.5M | $33.3M | $61.9M | $105.5M | $196.3M | $265.1M | $144.8M | $72.2M |
| Operating income | −$22.3M | −$45.7M | −$91.4M | −$157.1M | −$271.5M | −$322.4M | −$196.1M | −$122.2M |
| EBITDA | −$22.0M | −$45.5M | −$89.9M | −$155.5M | −$269.2M | −$312.9M | −$189.9M | −$108.1M |
| Net income | −$23.6M | −$43.5M | −$85.4M | −$153.5M | −$269.9M | −$320.0M | −$185.7M | −$115.8M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.71 | -2.20 | -1.72 | -3.10 | -5.01 | -5.06 | -2.14 | -1.30 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $0 | $-0.33 | $-0.33–$-0.33 | 1 |
| 2027 | $225M | $-0.25 | $-0.42–$-0.08 | 2 |
| 2028 | $189M | $-0.17 | $-0.17–$-0.17 | 1 |
| 2029 | $11M | $-0.20 | $-0.20–$-0.20 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds ALLK.
No tracked institution reports a position in ALLK as of their last filing.
No one on the platform has traded ALLK yet.
| $28M |
| — |
| HARPHarpoon Therapeutics, Inc. | $23.01 | +0.09% | $865M | — |
| KAKineta, Inc. | $0.57 | -30.77% | $7M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ALLK money laundering scheme.. once done, they let these die in 3-5 yrs later . Thats it , nothing else
View on StockTwits ↗$ALLK ive had this shit so long, but i didn't even realize it fell off my charts till today. $4500 gone. Fuck these guys.
View on StockTwits ↗$ALLK question... what happen to traders who not sign - money lost?
View on StockTwits ↗Wall St is expecting -0.30 EPS for $ALLK Q1 [Reporting 05/21 AMC] http://www.estimize.com/intro/allk?chart=historical&metric_name=eps&utm_c
View on StockTwits ↗$ALLK what a scam this was. Raised close to one billion and sell it for 35 million
View on StockTwits ↗$ALLK merger closes: Shareholders get $0.33 cash per share as Concentra takes control. Stock to be delisted effective today. Board resignations mark the end of an era for the once-promising biotech. For remaining holders, it's time to collect the check and move on. https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/ny20049047x1_8k.htm
View on StockTwits ↗$GRYP is doing what $ALLK is doing… you can buy into ($ALLK) if you want…. $ALLK TARGET Projection $8🎯
View on StockTwits ↗@Beetle_juice67 @MichaelSctock it’s ok atleast we’re not $ALLK
View on StockTwits ↗Wall St is expecting -0.30 EPS for $ALLK Q1 [Reporting 05/14 AMC] http://www.estimize.com/intro/allk?chart=historical&metric_name=eps&utm_c
View on StockTwits ↗Wall St is expecting -0.19 EPS for $ALLK Q2 [Reporting 08/06 AMC] http://www.estimize.com/intro/allk?chart=historical&metric_name=eps&utm_c
View on StockTwits ↗$SUNE and $ALLK have the least movement in my portfolio 😡 🧐 🤔
View on StockTwits ↗$ALLK On 12/5 Institutional Shares were 73,756,678 - 82.55% and today (4/15) Institutional Shares are now 75,318,708 - 84.30% 🤙
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.